𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dopa-responsive, nonprogressive, juvenile parkinsonism: Report of a case

✍ Scribed by Alex Rajput; Asha Kishore; B. Snow; C. F. Bolton; Dr. A. H. Rajput


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
488 KB
Volume
12
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Dopa-responsive, Nonprogressive, Juvenile

Parkinsonism: Report of a Case

The most common variant of Parkinson syndrome (PS) is Lewy body Parkinson's disease (1-3), also known as idiopathic Parkinson's disease (PD) (4). Most PD cases manifest at approximately age 60 years (5,6), but between 5 and 10% have onset before age 40 years (6,7) and are classified as early-onset parkinsonism (EOP). The EOP has been divided into two subgroups: juvenile parkinsonism (JP), with onset before age 21 years, and young-onset PD (YOPD), whose onset is between ages 21 and 40 years (8). The largest proportion of EOP patients have PD (9-12). There are many pathologically verified YOPD cases in the literature (13), but autopsy studies of JP are rare. One familial JP case who had onset as dystonia had PD (14), whereas another familial case did not have Lewy body (LB) pathology (15). Both of these cases, however, had hypopigmented substantia nigra (SN) ( 1 4 3 ) .

An overlap between dystonia and PS is well known. Compared with late-onset PD, the EOP cases are more likely to manifest as dystonia ( 16). This association is stronger in Dopa-responsive dystonia (DRD) cases. Some DRD cases simultaneously develop parkinsonism whereas, in others, parkinsonism evolves later in the course of illness (17)(18)(19)(20). Family members of DRD cases may develop de novo PS later in life and have a benign course (17,20). JP and DRD (with or without PS) each has onset in childhood, and the initial levodopa (LD) response is comparable in these two disorders. The long-term response, however, is different and is helpful in distinguishing between the two.

As stated by Nygaard et al., ". . . it is the sustained, smooth, therapeutic response in patients with DRD that separates these disorders" (17). Regardless of the onset ~~ A videotape accompanies this article.


πŸ“œ SIMILAR VOLUMES


Dopa-responsive parkinsonism phenotype o
✍ P. J. Tuite; E. A. Rogaeva; P. H. St George-Hyslop; Dr A. E. Lang πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 476 KB

Alternating hemiplegia syndrome: electroencephalogram, brain mapping and brain perfusion SPECT scan study in a Chinese girl. J. Child Neurol Bode H, Wick H. Abnormal #cerebral haemodynamics during attacks of alternating hemiplegia of childhood. Child New Syst Zupanc ML, Dobkin JA, Perlman SB. '"I-Io

Juvenile parkinsonism as a manifestation
✍ JosΓ© Manuel GarcΓ­a-Moreno; JosΓ© ChacΓ³n πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 71 KB

Involvement of the central nervous system in systemic lupus erythematosus (SLE) has been well described. It usually includes psychiatric disturbance, seizures, and cranial nerve disorders. Movement disorders are less common, chorea being the one most frequently described. A parkinsonian syndrome may

Juvenile plantar dermatosis: A report of
✍ Dr. J. M. Lachapelle; D. Tennstedt πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 697 KB

Juvenile plantar dermatosis (JPD) is a skin disease found mainly in children between the ages of 3 and 14 years old. External factors having a role in the development of the disease include: mechanical trauma, occlusive footwear (shoes and socks), and perhaps the seasons of the year. Data on gender,

Neuronal intranuclear inclusion disease:
✍ Dominic C. Paviour; Tamas Revesz; Janice L. Holton; Andrew Evans; Jan-Edvin Olss πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 133 KB

## Abstract Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disorder with a heterogeneous clinical picture characterized by the presence of eosinophilic intranuclear inclusions in neuronal and glial cells. We describe a case, reported 12 years ago as dopa‐responsive dysto